Sommaire

Numéro précédent | Numéro suivant

• • ·Migraine matters

    Page :877

     
• • ·The link between blood pressure and Alzheimer's disease

    Page :878-879

    Charles DeCarli

     
• • ·Preserving brain health after intracerebral haemorrhage

    Page :879-880

    Jonathan Rosand

     
• • ·Mesenchymal stem cells for multiple sclerosis: hype or hope?

    Page :881-882

    Reinhard Hohlfeld

    
• • ·Malformations of cortical development as models of altered brain excitability

    Page :882-883

    Andreas Schulze-Bonhage

    
• • ·The Lancet Neurology's 20th anniversary essay competition

    Page :884

    Elena Becker-Barroso, Laura Hart, Heather Brown, Sarah Passey

    
• • ·Advancing neuropalliative care

    Page :885

    Benzi M Kluger, Timothy E Quill

    
• • ·Advancing neuropalliative care

    Page :885-886

    Rajinder K Dhamija, Alvee Saluja, Janis Miyasaki

    
• • ·Advancing neuropalliative care

    Page :886

    Nathan A Shlobin, Mark Bernstein

    
• • ·Advancing neuropalliative care

    Page :887

    Milena Gandy, Louise Sharpe

    
• • ·Multiple sclerosis meets systems immunology

    Page :887-888

    Reinhard Hohlfeld

    
• • ·Multiple sclerosis meets systems immunology – Authors' reply

    Page :888

    Amit Bar-Or, Rui Li

    
• • ·Marie Vidailhet: recognising the importance of teamwork

    Page :889

    Priya Venkatesan

     
• • ·Charles Dodgson and Alice in Wonderland syndrome

    Page :890-891

    Jan Dirk Blom

      
• • ·Esme Ekizoglu Turgut

    Page :892

     
• • ·The retina as a window into the brain

    Page :892

    Peggy Frith, Arpan R Mehta

     
• • ·Art speaks where words fail

    Page :893

    Robert Stirrups

     
• • ·Sculpture and haptic deficit in the time of COVID-19

    Page :894

    Colin Martin

     
• • ·Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

    Page :895-906

    Patrick Gavin Kehoe, Nicholas Turner, Beth Howden, Lina Jarutyte, Shona Louise Clegg, Ian Brian Malone, Josephine Barnes, Casper Nielsen, Carole Hélène Sudre, Aileen Wilson, Ngoc Jade Thai, Peter Sinclair Blair, Elizabeth Coulthard, Janet Athene Lane, Peter Passmore, Jodi Taylor, Henk-Jan Mutsaerts, David Lee Thomas, Nick Charles Fox, Ian Wilkinson, Yoav Ben-Shlomo, RADAR investigators, Kirsty Harkness, Tarun Kuruvilla, Rupert McShane, Peter Connelly, Gordon Duncan, Lucy Calvert, Alasdair Lawrie, Matthew Sheridan, Eric Jackson, Bernard Udeze, Stephen Pearson, Tobias Langheinrich, Suvarna Wagle, Joseph Butchart, Ajay Macharouthu, Andrew Donaldson, Wendy Neil, Vivek Pattan, David Findlay, Alan Thomas, Robert Barber, Andrew Byrne, Madhusudan Dalvi, Rashi Negi, Bernadette McGuinness

    Résumé Résumé Plan Plan   
• • ·Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial

    Page :907-916

    Floris H B M Schreuder, Koen M van Nieuwenhuizen, Jeannette Hofmeijer, Sarah E Vermeer, Henk Kerkhoff, Elles Zock, Gert-Jan Luijckx, Gert P Messchendorp, Julia van Tuijl, H Paul Bienfait, Suzanne J Booij, Ido R van den Wijngaard, Michel J M Remmers, Antonia H C M L Schreuder, Diederik W Dippel, Julie Staals, Paul J A M Brouwers, Marieke J H Wermer, Jonathan M Coutinho, Vincent I H Kwa, Isabelle C van Gelder, Roger E G Schutgens, Berber Zweedijk, Ale Algra, Jan Willem van Dalen, L Jaap Kappelle, Gabriel J E Rinkel, H Bart van der Worp, Catharina J M Klijn, APACHE-AF Trial Investigators

    Résumé Résumé Plan Plan   
• • ·Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

    Page :917-929

    Antonio Uccelli, Alice Laroni, Rehiana Ali, Mario Alberto Battaglia, Morten Blinkenberg, Lou Brundin, Michel Clanet, Oscar Fernandez, James Marriott, Paolo Muraro, Seyed Massood Nabavi, Roberto S Oliveri, Ernst Radue, Cristina Ramo Tello, Irene Schiavetti, Johann Sellner, Per Soelberg Sorensen, Maria Pia Sormani, Jens Thomas Wuerfel, Mark S Freedman, MESEMS investigators, Naser Aghdami, Eduardo Agüera-Morales, Rehiana Ali, David Allan, Leila Arab, Mario Battaglia, Isabelle Berry, Morten Blinkenberg, Bruno Bonetti, Lou Brundin, Chiara Capelli, Lucio Castellan, Maria Cellerino, Maria Teresa Cencioni, Michel Clanet, Giancarlo Comi, David Courtman, Francesco Dazzi, Anne Fischer-Nielsen, Oscar Fernandez, Victoria Fernandez, Mark S. Freedman, Roberto Furlan, Mario Gimona, Francesca Gualandi, Qingdong Guan, Ellen Iacobaeus, Matilde Inglese, Martino Introna, Guillermo Izquierdo, Shahedeh Karimi, Alice Laroni, Katarina Le Blanc, Sandra Loaiza, Shahrukh Mallik, Stephen Marley, Ruth Ann Marrie, James Marriot, Gianvito Martino, Seyed Massood Nabavi, David Miller, Paolo A. Muraro, Richard Nicholas, Roberto S Oliveri, Giovanni Orengo, Renuka Palanicawande, Matteo Pardini, Ernst W Radue, Cristina Ramo Tello, Carolina Rush, Irene Schiavetti, Johann Sellner, Luc Sensebe, Per Soelberg Sorensen, Maria Pia Sormani, Dirk Strunk, David Szwajcer, Claire Thalamas, Antonio Uccelli, Jens Thomas Wuerfel

    Résumé Résumé Plan Plan   
• • ·Alzheimer's disease associated with Down syndrome: a genetic form of dementia

    Page :930-942

    Juan Fortea, Shahid H Zaman, Sigan Hartley, Michael S Rafii, Elizabeth Head, Maria Carmona-Iragui

    Résumé Résumé Plan Plan   
• • ·Neocortical development and epilepsy: insights from focal cortical dysplasia and brain tumours

    Page :943-955

    Ingmar Blumcke, Silvia Budday, Annapurna Poduri, Dennis Lal, Katja Kobow, Stephanie Baulac

    Résumé Résumé Plan Plan  
• • ·The role of manganese dysregulation in neurological disease: emerging evidence

    Page :956-968

    Dimitri Budinger, Serena Barral, Audrey K S Soo, Manju A Kurian

    Résumé Résumé Plan Plan